Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Inge H Briaire-de Bruijn"'
Autor:
Marieke E Ijsselsteijn, Ruud van der Breggen, Noel F C C de Miranda, Wilco C Peul, Judith V M G Bovée, Manon van der Ploeg, Siddh van Oost, Debora M Meijer, Jessica P Roelands, Brendy E M W van den Akker, Inge H Briaire-de Bruijn, Pauline M Wijers-Koster, Samuel B Polak, Robert J P van der Wal
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 1 (2024)
Background Chordomas are rare cancers from the axial skeleton which present a challenging clinical management with limited treatment options due to their anatomical location. In recent years, a few clinical trials demonstrated that chordomas can resp
Externí odkaz:
https://doaj.org/article/ef4dce943fec491c9d76c9c58ccb11a8
Autor:
David G P van IJzendoorn, Karoly Szuhai, Inge H Briaire-de Bruijn, Marie Kostine, Marieke L Kuijjer, Judith V M G Bovée
Publikováno v:
PLoS Computational Biology, Vol 15, Iss 2, p e1006826 (2019)
Based on morphology it is often challenging to distinguish between the many different soft tissue sarcoma subtypes. Moreover, outcome of disease is highly variable even between patients with the same disease. Machine learning on transcriptome sequenc
Externí odkaz:
https://doaj.org/article/9e8a83447ea14e8e946b9e8bebfb6a53
Autor:
Ieva Palubeckaitė, Sanne Venneker, Brendy E. W. M. van den Akker, Inge H. Briaire-de Bruijn, Judith V. M. G. Boveé
Publikováno v:
Clinical Orthopaedics & Related Research. 481:608-619
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a00a83eeffe49daab9a5f999e0177c27
https://doi.org/10.1097/corr.0000000000002483
https://doi.org/10.1097/corr.0000000000002483
Autor:
Yvonne de Jong, Fairuz Bennani, Jolieke G. van Oosterwijk, Gaia Alberti, Zuzanna Baranski, Pauline Wijers-Koster, Sanne Venneker, Inge H. Briaire-de Bruijn, Brendy E. van de Akker, Hans Baelde, Anne-Marie Cleton-Jansen, Bob van de Water, Erik H.J. Danen, Judith V.M.G. Bovée
Publikováno v:
Journal of Bone Oncology, Vol 19, Iss , Pp - (2019)
Chondrosarcomas are malignant cartilage tumors that are relatively resistant towards conventional therapeutic approaches. Kinase inhibitors have been investigated and shown successful for several different cancer types. In this study we aimed at iden
Externí odkaz:
https://doaj.org/article/518897c5759740c78f67b90a35c17d16
Autor:
Judith V.M.G. Bovée, Pancras C.W. Hogendoorn, Tom van Wezel, Antonie H.M. Taminiau, Jolieke van Oosterwijk, Noel F.C.C. de Miranda, Inge H. Briaire-de Bruijn, Yvonne M. Schrage
Supplementary Table 1 from Kinome Profiling of Chondrosarcoma Reveals Src-Pathway Activity and Dasatinib as Option for Treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::530e77c825e5ef61032aa61f44d91e6d
https://doi.org/10.1158/0008-5472.22377821.v1
https://doi.org/10.1158/0008-5472.22377821.v1
Autor:
Arjen H.G. Cleven, Karoly Szuhai, David G.P. van IJzendoorn, Eline Groen, Hans Baelde, Willem H. Schreuder, Inge H. Briaire-de Bruijn, Stijn W. van der Meeren, Maarten C. Kleijwegt, Wouter R. Furth, Herman M. Kroon, Albert J.H. Suurmeijer, Dilara C. Savci-Heijink, Daniel Baumhoer, Judith V.M.G. Bovée
Publikováno v:
Modern pathology, 36(1). Nature Publishing Group
Psammomatoid ossifying fibroma (PsOF), also known as juvenile PsOF, is a benign fibro-osseous neoplasm predominantly affecting the extragnathic bones, particularly the frontal and ethmoid bones, with a preference for adolescents and young adults. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd90b8727136527c682196c309263c57
https://pure.amc.nl/en/publications/psammomatoid-ossifying-fibroma-is-defined-by-satb2-rearrangement(1eb31481-81c3-455e-80c2-79c25f7f5b14).html
https://pure.amc.nl/en/publications/psammomatoid-ossifying-fibroma-is-defined-by-satb2-rearrangement(1eb31481-81c3-455e-80c2-79c25f7f5b14).html
Autor:
Sheena L M Ong, Isadora P Gomes, Hans J Baelde, Fabricio Passador‐Santos, Bruno A B de Andrade, Inge H Briaire‐de Bruijn, Israel L Cavalcante, Willem H Schreuder, Anne‐Marie Cleton‐Jansen, Arjen H G Cleven, Karoly Szuhai, Carolina C Gomes, Judith V M G Bovée
Publikováno v:
Histopathology. Wiley-Blackwell
Aims: Simple Bone Cysts (SBCs) predominantly occur in long bones and 59% harbour NFATC2 rearrangements. Jaw SBC is rare and was previously referred to as traumatic bone cyst. It can rarely occur in association with cemento-osseous dysplasia (COD). To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d67d36dfb17ea5acd08a48c0a2e98dfa
https://pure.amc.nl/en/publications/no-nfatc2-fusion-in-simple-bone-cyst-of-the-jaw(256612a9-d1f6-43cc-a7ca-4943873c6fb6).html
https://pure.amc.nl/en/publications/no-nfatc2-fusion-in-simple-bone-cyst-of-the-jaw(256612a9-d1f6-43cc-a7ca-4943873c6fb6).html
Autor:
Marie Kostine, Inge H. Briaire-de Bruijn, Arjen H. G. Cleven, Carly Vervat, Willem E. Corver, Marco W. Schilham, Els Van Beelen, Hester van Boven, Rick L. Haas, Antoine Italiano, Anne-Marie Cleton-Jansen, Judith V. M. G. Bovée
Publikováno v:
OncoImmunology, Vol 7, Iss 2 (2018)
Background: Immunotherapy may be a rational strategy in leiomyosarcoma (LMS), a tumor known for its genomic complexity. As a prerequisite for therapeutic applications, we characterized the immune microenvironment in LMS, as well as its prognostic val
Externí odkaz:
https://doaj.org/article/5f5612669cb946338c1500e09e6fb0fe
Autor:
Arjan Diepstra, Ronald van Eijk, Henriette Levenga, Valeska Terpstra, Joost S.P. Vermaat, Lizan Hardi, Richard Raghoo, Marie José Kersten, Tom van Wezel, Arjen H.G. Cleven, Dina Ruano, Liane te Boome, Inge H. Briaire-de Bruijn, Wietske C. E. den Hartog, Fleur A de Groot, Steven T. Pals, Patty M. Jansen, Isabelle Focke-Snieders, Hendrik Veelken, Pancras C.W. Hogendoorn, Marcel Nijland, Anke van den Berg, Pieternella J. Lugtenburg, Judith V.M.G. Bovée, Alina Nicolae, Karin Kleiverda, Ruben A.L. de Groen, Eduardus F. M. Posthuma, Stefan Böhringer, Lara H Böhmer
Publikováno v:
Blood Adv
Blood Advances, 5(19), 3760-3775. ELSEVIER
Blood Advances, 5(19):2021005215, 3760-3775. AMER SOC HEMATOLOGY
Blood advances, 5(19), 3760-3775. American Society of Hematology
Blood Advances, 5(19), 3760-3775. ELSEVIER
Blood Advances, 5(19):2021005215, 3760-3775. AMER SOC HEMATOLOGY
Blood advances, 5(19), 3760-3775. American Society of Hematology
Primary bone diffuse large B-cell lymphoma (PB-DLBCL) is a rare extranodal lymphoma subtype. This retrospective study elucidates the currently unknown genetic background of a large clinically well-annotated cohort of DLBCLwith osseous localizations (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::893bdaca8a68507a17b4f41ffca29462
https://doi.org/10.1182/bloodadvances.2021005215
https://doi.org/10.1182/bloodadvances.2021005215
Autor:
Sanne Venneker, Robin van Eenige, Alwine B. Kruisselbrink, Ieva Palubeckaitė, Alice E. Taliento, Inge H. Briaire-de Bruijn, Pancras C. W. Hogendoorn, Michiel A. J. van de Sande, Hans Gelderblom, Hailiang Mei, Judith V. M. G. Bovée, Karoly Szuhai
Publikováno v:
Cancers, 14(19). MDPI
Cancers; Volume 14; Issue 19; Pages: 4708
Cancers; Volume 14; Issue 19; Pages: 4708
Simple Summary: Giant cell tumor of bone (GCTB) is an intermediate bone neoplasm which consists of several cell populations, including the neoplastic "stromal" cells. These cells harbor a mutation in one of the histone H3.3 genes (H3F3A), and are the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::944cf9bf7c72590ead0d73214b3e5f5e
https://hdl.handle.net/1887/3512513
https://hdl.handle.net/1887/3512513